Unnamed: 0,title,date,stock,sentiment
920930.0,85 Biggest Movers From Yesterday,2020-06-04 05:02:00-04:00,NSPR,neutral
920931.0,Mid-Afternoon Market Update: Dow Surges 450 Points; Evofem Biosciences Shares Slide,2020-06-03 14:30:00-04:00,NSPR,positive
920932.0,58 Stocks Moving In Wednesday's Mid-Day Session,2020-06-03 12:18:00-04:00,NSPR,neutral
920933.0,Mid-Day Market Update: Gold Falls 2%; FSD Pharma Shares Spike Higher,2020-06-03 12:00:00-04:00,NSPR,positive
920934.0,InspireMD shares are trading lower after the company announced a 22.2222M unit offering priced at $0.45 per unit.,2020-06-03 08:27:00-04:00,NSPR,neutral
920935.0,InspireMD Announces 22.2222M Unit Offering To Be Priced At $0.45/Unit,2020-06-03 07:42:00-04:00,NSPR,neutral
920936.0,InspireMD shares are trading lower after the company reported a common stock offering.,2020-05-14 10:08:00-04:00,NSPR,neutral
920937.0,InspireMD S-1 Shows Registration For $11.5M Common Stock Offering,2020-05-14 09:57:00-04:00,NSPR,neutral
920938.0,"The Daily Biotech Pulse: NASH Disappointment For Genfit, Novavax Lands $384M CEPI Funding For Coronavirus Vaccine, GW Pharma Earnings",2020-05-12 08:06:00-04:00,NSPR,negative
920939.0,InspireMD shares are trading higher after the company reported better-than-expected Q1 EPS and sales results.,2020-05-12 07:19:00-04:00,NSPR,positive
920940.0,"InspireMD Q1 EPS $(0.430) Beats $(0.630) Estimate, Sales $1.034M Beat $1.000M Estimate",2020-05-12 07:18:00-04:00,NSPR,neutral
920941.0,"The Week Ahead In Biotech: Virtual Conference Presentations, Clovis PDUFA Date In The Spotlight",2020-05-10 15:40:00-04:00,NSPR,neutral
920942.0,UPDATE: Traders Suggest InspireMD Spike Higher Related To Slide 8 Of Presentation Showing 'Billion Dollar Market Opportunity' Related To Its MicroNet-Covered Stents Like CGuard Potentially Becoming 'The New Gold Standard',2020-04-06 13:01:00-04:00,NSPR,positive
920943.0,InspireMD Shares Spike Recently; Traders Circulating Co.'s Apr. 2020 Corporate Presentation,2020-04-06 13:00:00-04:00,NSPR,positive
920944.0,"H.C. Wainwright Reiterates Buy on InspireMD, Lowers Price Target to $2",2020-03-11 08:11:00-04:00,NSPR,negative
920945.0,"The Daily Biotech Pulse: Mesoblast To Test Candidate On Coronavirus Symptoms, Proxy Battle Ahead For Rockwell Medical, Glaukos to Join S&P SmallCap 600 Index",2020-03-10 09:19:00-04:00,NSPR,negative
920946.0,"InspireMD Q4 EPS $(1.22) Misses $(0.57) Estimate, Sales $1.013M Miss $1.6M Estimate",2020-03-10 08:01:00-04:00,NSPR,negative
920947.0,"The Week Ahead In Biotech (March 8-14): Bristol-Myers Awaits FDA Nod For Liver Cancer Combo Therapy, Earnings Flow Continues",2020-03-08 16:14:00-04:00,NSPR,negative
920948.0,InspireMD ; Sees Q4 Sales $1M-1.25M,2020-01-06 08:21:00-05:00,NSPR,neutral
920949.0,InspireMD Announces Planned Leadership Transition,2019-12-10 08:02:00-05:00,NSPR,neutral
920950.0,InspireMD Offers Updated CGuard Data Presented At VEITH 2019,2019-11-26 08:15:00-05:00,NSPR,neutral
920951.0,"InspireMD, Inc. Common Stock Q3 EPS $(1.26) Beats $(1.35) Estimate, Sales $939K Miss $1.4M Estimate",2019-11-12 07:50:00-05:00,NSPR,negative
920952.0,"The Daily Biotech Pulse: Reata, Kadmon Clinical Readouts, Apyx Medical's Earnings Beat",2019-11-12 07:20:00-05:00,NSPR,neutral
920953.0,45 Biggest Movers From Friday,2019-09-23 06:08:00-04:00,NSPR,neutral
920954.0,Mid-Afternoon Market Update: U.S. Stocks Turn Lower; Roku Shares Plummet,2019-09-20 14:41:00-04:00,NSPR,neutral
920955.0,36 Stocks Moving In Friday's Mid-Day Session,2019-09-20 12:23:00-04:00,NSPR,neutral
920956.0,Mid-Day Market Update: McDermott Surges After Takeover Bids For Lummus Technology; InspireMD Shares Fall,2019-09-20 12:03:00-04:00,NSPR,positive
920957.0,Mid-Morning Market Update: Markets Open Higher; Steelcase Tops Q2 Estimates,2019-09-20 10:17:00-04:00,NSPR,positive
920958.0,InspireMD shares are trading lower after the company priced its underwritten public offering of 2.77 million units at $1.80 per unit.,2019-09-20 07:49:00-04:00,NSPR,neutral
920959.0,"The Daily Biotech Pulse: FDA Approves Merck HIV Drugs, Five Prime CEO Quits, HTG Molecular Announces Secondary Offering",2019-09-20 07:46:00-04:00,NSPR,positive
920960.0,26 Stocks Moving in Friday's Pre-Market Session,2019-09-20 07:42:00-04:00,NSPR,neutral
920961.0,46 Biggest Movers From Yesterday,2019-09-20 04:45:00-04:00,NSPR,neutral
920962.0,"5 Stocks To Watch For September 20, 2019",2019-09-20 04:21:00-04:00,NSPR,neutral
920963.0,InspireMD Prices 2.77M Unit Underwritten Public Offering @$1.80/Unit,2019-09-20 03:55:00-04:00,NSPR,neutral
920964.0,52 Biggest Movers From Yesterday,2019-09-19 05:18:00-04:00,NSPR,neutral
920965.0,36 Stocks Moving In Wednesday's Mid-Day Session,2019-09-18 13:19:00-04:00,NSPR,neutral
920966.0,30 Stocks Moving in Wednesday's Pre-Market Session,2019-09-18 07:52:00-04:00,NSPR,neutral
920967.0,65 Biggest Movers From Yesterday,2019-09-18 06:53:00-04:00,NSPR,neutral
920968.0,Weighing Opportunity And Risk In A Slow September,2019-09-13 14:04:00-04:00,NSPR,positive
920969.0,71 Biggest Movers From Yesterday,2019-09-12 05:33:00-04:00,NSPR,neutral
920970.0,48 Stocks Moving In Wednesday's Mid-Day Session,2019-09-11 12:27:00-04:00,NSPR,neutral
920971.0,80 Biggest Movers From Yesterday,2019-09-11 05:11:00-04:00,NSPR,neutral
920972.0,50 Stocks Moving In Tuesday's Mid-Day Session,2019-09-10 12:19:00-04:00,NSPR,neutral
920973.0,InspireMD Shares Resume Trade,2019-09-10 09:52:00-04:00,NSPR,positive
920974.0,InspireMD Shares Halted On Circuit Breaker,2019-09-10 09:48:00-04:00,NSPR,positive
920975.0,66 Biggest Movers From Yesterday,2019-09-04 05:07:00-04:00,NSPR,neutral
920976.0,50 Biggest Movers From Yesterday,2019-08-27 05:20:00-04:00,NSPR,neutral
920977.0,30 Stocks Moving In Monday's Mid-Day Session,2019-08-26 12:40:00-04:00,NSPR,neutral
920978.0,26 Stocks Moving in Monday's Pre-Market Session,2019-08-26 08:00:00-04:00,NSPR,neutral
920979.0,66 Biggest Movers From Yesterday,2019-08-23 05:05:00-04:00,NSPR,neutral
920980.0,26 Stocks Moving in Thursday's Pre-Market Session,2019-08-22 07:50:00-04:00,NSPR,neutral
920981.0,48 Stocks Moving In Monday's Mid-Day Session,2019-08-19 13:33:00-04:00,NSPR,neutral
920982.0,"InspireMD Says Expects To Submit Compliance Plan To NYSE American On Or Before Sep. 6, 2019",2019-08-09 16:34:00-04:00,NSPR,neutral
920983.0,85 Biggest Movers From Yesterday,2019-08-07 05:39:00-04:00,NSPR,neutral
920984.0,68 Stocks Moving In Tuesday's Mid-Day Session,2019-08-06 13:55:00-04:00,NSPR,neutral
920985.0,InspireMD Q2 EPS $(1.59) Beats $(2) Estimate,2019-08-06 07:57:00-04:00,NSPR,neutral
920986.0,64 Biggest Movers From Yesterday,2019-05-30 05:08:00-04:00,NSPR,neutral
920987.0,42 Stocks Moving In Wednesday's Mid-Day Session,2019-05-29 12:36:00-04:00,NSPR,neutral
920988.0,58 Biggest Movers From Yesterday,2019-05-15 05:09:00-04:00,NSPR,neutral
920989.0,40 Stocks Moving In Tuesday's Mid-Day Session,2019-05-14 12:43:00-04:00,NSPR,neutral
920990.0,"The Daily Biotech Pulse: Further Delay in Roche's Spark Acquisition, FDA Nod For Regeneron, Solid Biosciences Sinks On Earnings",2019-05-14 07:42:00-04:00,NSPR,positive
920991.0,"InspireMD Q1 EPS $(3.82) Down From $(1.08) YoY, Sales $415K Down From $1.007M YoY",2019-05-14 07:07:00-04:00,NSPR,neutral
920992.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Morning of Fri., May 3, 2019",2019-05-03 10:22:00-04:00,NSPR,positive
920993.0,78 Biggest Movers From Yesterday,2019-05-03 05:08:00-04:00,NSPR,neutral
920994.0,54 Stocks Moving In Thursday's Mid-Day Session,2019-05-02 12:09:00-04:00,NSPR,neutral
920995.0,InspireMD shares are trading higher on no apparent news. The stock may be trading higher in sympathy with ARCA Biopharma.,2019-05-02 09:22:00-04:00,NSPR,positive
920996.0,42 Biggest Movers From Yesterday,2019-04-30 07:05:00-04:00,NSPR,neutral
920997.0,28 Stocks Moving In Thursday's Pre-Market Session,2019-04-11 08:03:00-04:00,NSPR,neutral
920998.0,Empery Asset Management Reports 7.36% Passive Stake In InspireMD,2019-04-10 13:09:00-04:00,NSPR,positive
920999.0,Sabby Announces 7.85% Passive Stake In Inspire MD,2019-04-08 13:00:00-04:00,NSPR,positive
921000.0,52 Biggest Movers From Yesterday,2019-04-05 05:55:00-04:00,NSPR,neutral
921001.0,Mid-Afternoon Market Update: Dow Up 135 Points; Recro Pharma Shares Spike Higher,2019-04-04 14:36:00-04:00,NSPR,positive
921002.0,44 Stocks Moving In Thursday's Mid-Day Session,2019-04-04 12:39:00-04:00,NSPR,neutral
921003.0,Mid-Day Market Update: Resources Connection Falls After Q3 Results; Tonix Pharmaceuticals Shares Surge,2019-04-04 12:12:00-04:00,NSPR,positive
921004.0,Mid-Morning Market Update: Markets Open Higher; Constellation Brands Tops Q4 Estimates,2019-04-04 10:08:00-04:00,NSPR,positive
921005.0,InpsireMD Inc. shares are trading lower after the company announced a $2.4 million public offering of common stock priced at $5 per share.,2019-04-04 09:55:00-04:00,NSPR,positive
921006.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Morning Of Thurs., Apr. 4, 2019",2019-04-04 09:45:00-04:00,NSPR,positive
921007.0,32 Stocks Moving In Thursday's Pre-Market Session,2019-04-04 08:18:00-04:00,NSPR,neutral
921008.0,"The Daily Biotech Pulse: Recro Restructures, Biotechs Raise Proceeds In Droves, Silk Road, NGM Biopharma To Debut",2019-04-04 07:58:00-04:00,NSPR,neutral
921009.0,InspireMD Prices ~487K Share Offering At $5/Share,2019-04-04 06:03:00-04:00,NSPR,positive
921010.0,InspireMD Prices 487K Share Public Offering of Common Stock @$5/Share,2019-04-04 06:02:00-04:00,NSPR,positive
921011.0,55 Biggest Movers From Yesterday,2019-04-04 05:19:00-04:00,NSPR,neutral
921012.0,"InspireMD Reports Offering Of Common Stock, No Size Disclosed",2019-04-03 16:07:00-04:00,NSPR,negative
921013.0,40 Stocks Moving In Wednesday's Mid-Day Session,2019-04-03 12:41:00-04:00,NSPR,neutral
921014.0,30 Stocks Moving In Wednesday's Pre-Market Session,2019-04-03 08:04:00-04:00,NSPR,neutral
921015.0,54 Biggest Movers From Yesterday,2019-04-03 05:42:00-04:00,NSPR,neutral
921016.0,"InspireMD Reports 1-For-50 Reverse Stock Split, Effective Mar. 29, 2019",2019-03-26 07:08:00-04:00,NSPR,positive
921017.0,"InspireMD Q4 EPS $(0.05) Up From $(7.38) YoY, Sales $822K Down From $833K YoY",2019-02-19 07:20:00-05:00,NSPR,neutral
921018.0,"The Week Ahead In Biotech: Conferences, Clinical Trials And Earnings",2019-02-15 14:00:00-05:00,NSPR,neutral
921019.0,UPDATE: InspireMD Says 'CGuard™ EPS shows encouraging interim results verses a conventional carotid stent in absence of any adverse clinical events in the CGuard™ arm',2019-01-24 08:09:00-05:00,NSPR,positive
921020.0,InspireMD Highlights Presentation Of Interim Data From Investigator-Initiated Study Comparing CGuard EPS With Conventional Open-Cell Carotid Stent,2019-01-24 08:08:00-05:00,NSPR,neutral
921021.0,InspireMD shares are trading higher after the company announced two successful live clinical clinical case transmissions featuring CGuard EPS.,2019-01-23 09:33:00-05:00,NSPR,positive
921022.0,InspireMD Announces Results From Initial Clinical Study Of CGuard Embolic Prevention System (EPS) With SmartFit Technology,2019-01-22 08:16:00-05:00,NSPR,neutral
921023.0,"InspireMD Announced That Its Cguard Carotid Embolic Prevention System Will Be Featured In Two Live Case Transmissions At The Leipzig Interventional Course 2019 To Be Held From January 22-25 At The Trade Fair Leipzig, Hall 2 In Leipzig, Germany",2019-01-18 09:43:00-05:00,NSPR,positive
921024.0,InspireMD Reports Received Noncompliance Notice From NYSE American,2019-01-11 16:35:00-05:00,NSPR,neutral
921025.0,"Stocks Which Set New 52-Week Low Yesterday, Tues., Dec. 18, 2018",2018-12-19 12:43:00-05:00,NSPR,negative
921026.0,"InspireMD Reports Long-Term Safety, Efficacy Data From Ongoing CGuard EPS Registries At Symposium on Vascular and Endovascular Issues, Techniques, Horizons",2018-11-29 08:02:00-05:00,NSPR,positive
921027.0,InspireMD Announces Regulatory And Reimbursement Approval Of CGuard Embolic Prevention System In Australia,2018-11-28 08:04:00-05:00,NSPR,positive
921028.0,"InspireMD, Inc. Common Stock Q3 EPS $(0.05) Up From $(0.19) YoY, Sales $769K Up From $718K YoY",2018-11-06 07:29:00-05:00,NSPR,neutral
921029.0,"The Daily Biotech Pulse: EyePoint Licenses Eye Inflammation Drug, Insys Strategic Review Of Opioid Assets, Neos Offering",2018-11-06 07:04:00-05:00,NSPR,positive
921030.0,"The Week Ahead In Biotech: Earnings, Conferences, PDUFA Dates, Clinical Trial Results And IPOs",2018-11-04 13:35:00-05:00,NSPR,neutral
921031.0,UPDATE: InspireMD Highlights 'absence of any device related issues in the first 93 of the 251 patients in the PARADIGM-Extend cohort',2018-09-27 09:31:00-04:00,NSPR,neutral
921032.0,"InspireMD Reports Prelim. Cumulative 3-Year Follow-Up Safety, Efficacy, Stroke Prevention Durability Data From CGuard Trial: 'data showed no stroke or stroke-related deaths between 24 and 36 months...'",2018-09-27 09:30:00-04:00,NSPR,positive
921033.0,InspireMD Announces Regulatory Approval of CGuard Embolic Prevention System in Mexico,2018-09-24 08:01:00-04:00,NSPR,positive
921034.0,"Stocks Which Set New 52-Week Low Yesterday, September 19th",2018-09-20 11:26:00-04:00,NSPR,negative
921035.0,"Stocks Which Set New 52-Week Low Yesterday, September 17th",2018-09-18 09:27:00-04:00,NSPR,negative
921036.0,36 Stocks Moving In Monday's Mid-Day Session,2018-09-17 12:27:00-04:00,NSPR,neutral
921037.0,InspireMD shares are up 10.6% premarket after the company was issued two new patents covering its MicroNet stent jacket and related drug and related drug eluting Technology.,2018-09-17 09:18:00-04:00,NSPR,positive
921038.0,InspireMD Announces Issuance of Two New U.S. Patents Covering Proprietary MicroNet Stent Jacket and Related Drug Eluting Technology,2018-09-17 08:02:00-04:00,NSPR,neutral
921039.0,"Stocks Which Set New 52-Week Low Yesterday, August 16th",2018-08-17 10:40:00-04:00,NSPR,negative
921040.0,"Stocks Which Set New 52-Week Low Yesterday, August 15th",2018-08-16 11:15:00-04:00,NSPR,negative
921041.0,"The Daily Biotech Pulse: FDA Snub For Gemphire, Ligand Earnings, Insmed's Antibiotic Faces FDA Panel",2018-08-07 08:23:00-04:00,NSPR,negative
921042.0,InspireMD shares up 7.9% after the company reported a year-over-year increase in Q2 EPS and Sales as well as a 94% increase in CGuard EPS revenues.,2018-08-06 17:51:00-04:00,NSPR,positive
921043.0,"InspireMD Q2 EPS $(0.15) Up From $(0.21) YoY, Sales $1.003M Up From $640K YoY",2018-08-06 17:18:00-04:00,NSPR,neutral
921044.0,44 Biggest Movers From Friday,2018-07-02 04:48:00-04:00,NSPR,neutral
921045.0,Mid-Afternoon Market Update: Echelon Climbs On Acquisition News; InspireMD Shares Slide,2018-06-29 14:25:00-04:00,NSPR,positive
921046.0,35 Stocks Moving In Friday's Mid-Day Session,2018-06-29 12:18:00-04:00,NSPR,neutral
921047.0,Mid-Day Market Update: Crude Oil Up Over 1%; Gemphire Therapeutics Shares Spike Higher,2018-06-29 12:04:00-04:00,NSPR,negative
921048.0,CORRECTION: InspireMD Prices ~33.33M Unit Offering At $0.30/Unit; Initial headline said $0.03/unit; this was incorrect,2018-06-29 10:26:00-04:00,NSPR,neutral
921049.0,InspireMD Prices ~33.33M Unit Offering At $0.30/Unit,2018-06-29 10:24:00-04:00,NSPR,neutral
921050.0,41 Biggest Movers From Yesterday,2018-05-31 04:45:00-04:00,NSPR,neutral
921051.0,30 Stocks Moving In Wednesday's Mid-Day Session,2018-05-30 12:26:00-04:00,NSPR,neutral
921052.0,"UPDATE: InspireMD On CGuard EPS Trial Results: 'There was 1 minor peri-procedural stroke (0.4%), and only 1 death (non-device related) at 30 days (0.4%).'",2018-05-30 09:53:00-04:00,NSPR,negative
921053.0,"UPDATE: InspireMD Says Latest Results For CGuard EPS Included 251 Patients, More Than Double From Prior Results, Overall Data Showed 'no major strokes in the peri-procedural or post-procedural period up to 30 days (0%).'",2018-05-30 09:52:00-04:00,NSPR,negative
921054.0,InspireMD Shares Rise 25% Following PR Announcing Sustained Benefit of CGuard EPS,2018-05-30 09:36:00-04:00,NSPR,positive
921055.0,InspireMD Receives Regulatory Approval for both CGuard EPS and MGuard Prime in Ecuador,2018-05-16 08:12:00-04:00,NSPR,positive
921056.0,"InspireMD Q1 EPS $(1.08) vs $(28.31) In Same Qtr. Last Year, Sales $1.007M vs $569K YoY",2018-05-07 16:46:00-04:00,NSPR,neutral
921057.0,"Low-Float Stocks Winning Trader Interest This Week: Integrated Media (IMTE) Up ~1,300% Wed., Boxlight (BOXL) Up 81.7%, InVivo (NVIV) Up 64%, Sharing Economy (SEII) Up 53%, InspireMD (NSPR) Up 13.8%; Not Seeing News On Any Of These Names",2018-05-02 13:32:00-04:00,NSPR,positive
921058.0,"InspireMD Shares Up 10.8% Wed., Continuing Higher Following 9% Rally On Mon. Amid Regulatory Approval, Reimbursement For CGuard EPS, MGuard Prime In Vietnam; Stock Likely Viewed As Low-Float Play, Has 5.86M Shares Outstanding",2018-05-02 11:23:00-04:00,NSPR,positive
921059.0,InspireMD Stock Rallies After Vietnam Approves Embolism Prevention Products,2018-04-30 16:05:00-04:00,NSPR,positive
921060.0,"Benzinga Pro's Most-Searched Tickers For Morning Of Mon., Apr. 30, 2018",2018-04-30 10:15:00-04:00,NSPR,neutral
921061.0,InspireMD Announces Regulatory Approval and Reimbursement to Commercialize both CGuard EPS and MGuard Prime Products in Vietnam,2018-04-30 07:52:00-04:00,NSPR,positive
921062.0,"InspireMD Q1 Sales $1M+ vs $569K In Same Qtr. Last Year, Total CGuard EPS Sales $831K+",2018-04-03 10:28:00-04:00,NSPR,neutral
921063.0,40 Biggest Movers From Yesterday,2018-03-29 05:08:00-04:00,NSPR,neutral
921064.0,Mid-Afternoon Market Update: RH Rises On Upbeat Earnings; InspireMD Shares Slide,2018-03-28 14:30:00-04:00,NSPR,positive
921065.0,32 Stocks Moving In Wednesday's Mid-Day Session,2018-03-28 12:45:00-04:00,NSPR,neutral
921066.0,Mid-Day Market Update: Crude Oil Down Over 1%; Edge Therapeutics Shares Plunge,2018-03-28 12:14:00-04:00,NSPR,negative
921067.0,InspireMD Shares Down 35% After Co. Earlier Priced 2.86M Share Offering At $1.75/Share,2018-03-28 11:01:00-04:00,NSPR,positive
921068.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Wed., Mar. 28, 2018",2018-03-28 10:58:00-04:00,NSPR,positive
921069.0,Mid-Morning Market Update: Markets Mixed; Walgreens Beats Q2 Views,2018-03-28 10:15:00-04:00,NSPR,neutral
921070.0,InspireMD Prices ~2.857M Share Offering At $1.75/Share,2018-03-28 06:30:00-04:00,NSPR,positive
921071.0,38 Biggest Movers From Yesterday,2018-03-28 05:19:00-04:00,NSPR,neutral
921072.0,"InspireMD Reports Offering Of Common Stock, No Size Disclosed",2018-03-27 16:38:00-04:00,NSPR,negative
921073.0,"Benzinga Pro's Most-Searched Tickers For Tues., Mar. 27, 2018",2018-03-27 15:58:00-04:00,NSPR,neutral
921074.0,Mid-Afternoon Market Update: NASDAQ Down Over 100 Points; Invitae Shares Fall Following Announcement Of $50M Common Stock Offering,2018-03-27 14:33:00-04:00,NSPR,positive
921075.0,InspireMD Shares Up ~27% After Earlier Reporting Receipt of Regulatory Approval For CGuard EPS And MGuard Prime In Peru,2018-03-27 13:09:00-04:00,NSPR,positive
921076.0,30 Stocks Moving In Tuesday's Mid-Day Session,2018-03-27 12:31:00-04:00,NSPR,neutral
921077.0,Mid-Day Market Update: Dow Rises Over 100 Points; InspireMD Shares Spike Higher,2018-03-27 12:01:00-04:00,NSPR,positive
921078.0,Mid-Morning Market Update: Markets Edge Lower; McCormick Profit Tops Estimates,2018-03-27 10:20:00-04:00,NSPR,positive
921079.0,24 Stocks Moving In Tuesday's Pre-Market Session,2018-03-27 08:02:00-04:00,NSPR,neutral
921080.0,InspireMD Receives Regulatory Approval for both CGuard EPS and MGuard Prime in Peru,2018-03-27 07:03:00-04:00,NSPR,positive
921081.0,32 Stocks Moving In Thursday's Pre-Market Session,2018-03-08 08:06:00-05:00,NSPR,neutral
921082.0,42 Biggest Movers From Yesterday,2018-02-28 04:49:00-05:00,NSPR,neutral
921083.0,Mid-Afternoon Market Update: Crude Oil Down 1.5%; Mallinckrodt Shares Climb After Strong Q4 Results,2018-02-27 14:30:00-05:00,NSPR,positive
921084.0,InspireMD Shares Down 29.9% Following Announcement Of 1M Share Offering At $3/Share,2018-02-27 12:43:00-05:00,NSPR,positive
921085.0,35 Stocks Moving In Tuesday's Mid-Day Session,2018-02-27 12:32:00-05:00,NSPR,neutral
921086.0,Mid-Day Market Update: U.S. Stocks Turn Lower; Dillard's Shares Gain On Earnings Beat,2018-02-27 12:00:00-05:00,NSPR,positive
921087.0,Mid-Morning Market Update: Markets Open Higher; Macy's Profit Tops Estimates,2018-02-27 10:20:00-05:00,NSPR,positive
921088.0,22 Stocks Moving In Tuesday's Pre-Market Session,2018-02-27 07:47:00-05:00,NSPR,neutral
921089.0,InspireMD Prices 1M Share Offering At $3/Share,2018-02-27 07:04:00-05:00,NSPR,positive
921090.0,10 Stocks Moving In Monday's After-Hours Session,2018-02-26 18:28:00-05:00,NSPR,neutral
921091.0,"InspireMD Shares Down 14.5% After Hours As Co. Announced Offering Of Common Stock, No Size Disclosed",2018-02-26 16:32:00-05:00,NSPR,neutral
921092.0,"InspireMD Reports Offering Of Common Stock, No Size Disclosed",2018-02-26 16:08:00-05:00,NSPR,negative
921093.0,InspireMD Shares Seeing Notable Volume As Traders Circulate A Co. Presentation Highlighting MicroNet Products,2018-02-26 14:45:00-05:00,NSPR,positive
921094.0,"InspireMD Shares Resume Trade, Now Up ~16% At $4.89/Share",2018-02-22 10:38:00-05:00,NSPR,positive
921095.0,"InspireMd Shares Resumed Trade, Spiked Into Positive Territory, Now Up ~4.8%, Halted On Second Circuit Breaker Of Session",2018-02-22 10:30:00-05:00,NSPR,positive
921096.0,"InspireMD Shares Halted On Circuit Breaker, Down 2% For Session; Well Off Session Lows",2018-02-22 10:18:00-05:00,NSPR,positive
921097.0,"InspireMD Reports Exclusive Distribution, Sales and Marketing Agreement for CGuard EPS in South Korea With Solvit Medical",2018-02-22 10:17:00-05:00,NSPR,positive
921098.0,46 Biggest Movers From Yesterday,2018-02-16 05:19:00-05:00,NSPR,neutral
921099.0,22 Stocks Moving In Thursday's Pre-Market Session,2018-02-15 08:41:00-05:00,NSPR,neutral
921100.0,42 Biggest Movers From Yesterday,2018-02-15 04:43:00-05:00,NSPR,neutral
921101.0,36 Stocks Moving In Wednesday's Mid-Day Session,2018-02-14 12:52:00-05:00,NSPR,neutral
921102.0,Mid-Day Market Update: U.S. Stocks Turn Higher; Tetraphase Pharmaceuticals Shares Plummet,2018-02-14 12:37:00-05:00,NSPR,positive
921103.0,Mid-Morning Market Update: Markets Mostly Lower; Groupon Profit Misses Views,2018-02-14 10:07:00-05:00,NSPR,negative
921104.0,"InspireMD Reports Q4 EPS $(7.38) vs $(30.59) In Same Qtr. Last Year, Sales $833K",2018-02-14 07:37:00-05:00,NSPR,neutral
921105.0,46 Biggest Movers From Yesterday,2018-02-09 04:36:00-05:00,NSPR,neutral
921106.0,45 Stocks Moving In Thursday's Mid-Day Session,2018-02-08 12:25:00-05:00,NSPR,neutral
921107.0,"InspireMD Announces 1-for-35 Reverse Stock Split, Effective February 7th",2018-02-07 14:36:00-05:00,NSPR,positive
921108.0,InspireMD Reports CGuard Embolic Prevention System Featured In Second Live Case Transmission At LINC '18,2018-01-31 08:31:00-05:00,NSPR,neutral
921109.0,InspireMD Reports CGuard Embolic Prevention System Featured In Successful Live Case Transmissions At LINC '18,2018-01-30 08:25:00-05:00,NSPR,positive
921110.0,InspireMD's CGuard Embolic Prevention System to be Prominently Featured in Two Live Case Transmissions at LINC 2018,2018-01-26 10:14:00-05:00,NSPR,neutral
921111.0,InspireMD Reports Publication Of Independent Imaging Study Highlighting Advantages Of CGuard EPS vs Another Next Gen Carotid Stent,2018-01-19 10:19:00-05:00,NSPR,positive
921112.0,InspireMd Sees Q4 Sales Of CGuard EPS ~$606K,2018-01-10 07:32:00-05:00,NSPR,neutral
921113.0,InspireMD Sees Q4 Sales ~$833K,2018-01-10 07:32:00-05:00,NSPR,neutral
921114.0,"UPDATE: InspireMD Reports Signing Of Deal With Leading Indian Medical Device Distributor, No Terms Disclosed",2018-01-03 08:57:00-05:00,NSPR,negative
921115.0,InspireMD Reports Regulatory Approval Of CGuard EPS In India,2018-01-03 08:56:00-05:00,NSPR,positive
921116.0,InspireMD Reports 24-Month Follow Up Results For PARADIGM Clincial Study Using CGUARD EPS,2017-12-05 13:04:00-05:00,NSPR,neutral
921117.0,InspireMD Announces a $750K Convertible Preferred Share Offering,2017-11-29 07:06:00-05:00,NSPR,positive
921118.0,"InspireMD Reports Q3 EPS $(0.19) vs. $(0.85) In Same Qtr. Last Year, Sales $718K vs. $469K YoY",2017-11-07 16:45:00-05:00,NSPR,neutral
921119.0,InspireMD Reports Distribution Agreement With CorpMedical Chile for MGuard Prime(TM) in Chile,2017-10-12 10:39:00-04:00,NSPR,positive
921120.0,"InspireMD Reports Postponement Of Special Meeting Of Holders To Oct. 27, 2017",2017-10-04 09:06:00-04:00,NSPR,positive
921121.0,"Companies Holding Special Shareholder Meetings Today Include D.R. Horton, InspireMD, and Wolverine Bancorp",2017-10-03 09:04:00-04:00,NSPR,positive
921122.0,"The Week Ahead: 3 IPOs, Jobs Report, And Earnings Season Nears",2017-10-02 10:06:00-04:00,NSPR,neutral
921123.0,InspireMD Reports Distribution Deal For CGuard EPS In Portugal,2017-09-21 07:31:00-04:00,NSPR,neutral
921124.0,"InspireMD Reports Notification Of NYSE AMERICAN Listing Deficiency, Expectation To Regain Compliance",2017-08-22 08:02:00-04:00,NSPR,neutral
921125.0,"InspireMD Reports Q2 EPS $(0.21), Sales $640K",2017-08-08 18:00:00-04:00,NSPR,neutral
921126.0,"Inspiremd has Signed Distribution Agreements for Cguard!"" EEPS With Comesa Gmbh",2017-06-13 11:41:00-04:00,NSPR,positive
921127.0,InspireMD Reports Distribution Deal for CGuard EPS in Poland,2017-06-05 08:23:00-04:00,NSPR,neutral
921128.0,InspireMD Names Paul Stuka Chair,2017-06-02 08:48:00-04:00,NSPR,neutral
921129.0,"InspireMD Shares Recently Turn Positive, Now Up 6%; Traders Circulating Report Co. Received Intent to Grant Notice from European Patent Office for Its MicroNet Product",2017-05-03 12:53:00-04:00,NSPR,positive
921130.0,InspireMD Announces Distribution Agreement for CGuard EPS in Germany,2017-05-01 13:08:00-04:00,NSPR,positive
921131.0,InspireMD Announces ab medica Deutschland to Distribute CGuard in Germany,2017-05-01 07:35:00-04:00,NSPR,neutral
921132.0,Mid-Afternoon Market Update: U.S. Stocks Turn Negative; Tailored Brands Shares Slide,2017-03-09 14:32:00-05:00,NSPR,negative
921133.0,18 Biggest Mid-Day Losers For Thursday,2017-03-09 12:47:00-05:00,NSPR,negative
921134.0,Mid-Day Market Update: Crude Oil Down Over 2%; Comtech Shares Spike Higher,2017-03-09 12:08:00-05:00,NSPR,negative
921135.0,18 Biggest Mid-Day Losers For Wednesday,2017-03-08 13:21:00-05:00,NSPR,negative
921136.0,15 Biggest Mid-Day Gainers For Tuesday,2017-01-10 12:27:00-05:00,NSPR,neutral
921137.0,20 Stocks Moving In Tuesday's Pre-Market Session,2017-01-10 08:24:00-05:00,NSPR,neutral
921138.0,18 Stocks Moving In Friday's Pre-Market Session,2016-12-23 08:12:00-05:00,NSPR,neutral
921139.0,InspireMD Spikes to High of $3.25 on Volume,2016-11-21 14:43:00-05:00,NSPR,neutral
921140.0,InspireMD Inc Shares Spiking Higher,2016-11-21 14:43:00-05:00,NSPR,positive
921141.0,"InspireMD Reports Q3 EPS $(0.86, Revenues $469K",2016-11-14 16:18:00-05:00,NSPR,neutral
921142.0,InspireMD Announces CGuard Embolic Prevention System Commercialization Approval in Russia,2016-11-14 07:13:00-05:00,NSPR,positive
921143.0,Mid-Afternoon Market Update: Dow Falls 150 Points; Pitney Bowes Shares Down On Earnings Miss,2016-11-01 15:06:00-04:00,NSPR,positive
921144.0,15 Biggest Mid-Day Gainers For Tuesday,2016-11-01 13:55:00-04:00,NSPR,neutral
921145.0,Mid-Day Market Update: InspireMD Jumps Following Positive CGuard Results; Neovasc Shares Drop,2016-11-01 12:11:00-04:00,NSPR,positive
921146.0,Mid-Morning Market Update: Markets Edge Lower; Pfizer Profit Misses Views,2016-11-01 10:24:00-04:00,NSPR,negative
921147.0,InspireMD Resumes Trade +130%,2016-11-01 09:51:00-04:00,NSPR,neutral
921148.0,InspireMD Halted on CB,2016-11-01 09:48:00-04:00,NSPR,neutral
921149.0,InspireMD +70% @ $2.44 Following Press Release Announcing Positive CGuard Results,2016-11-01 09:47:00-04:00,NSPR,positive
921150.0,InspireMD Inc. Halted,2016-11-01 09:30:00-04:00,NSPR,neutral
921151.0,12 Biggest Mid-Day Losers For Monday,2016-10-17 13:27:00-04:00,NSPR,negative
921152.0,8 Biggest Mid-Day Gainers For Wednesday,2016-10-12 12:13:00-04:00,NSPR,neutral
921153.0,"InspireMD Shares Continue Higher Today, Up ~31%; Stock Up 80+% Since Closing of 1-for-25 Reverse Split on Mon., Oct 10",2016-10-12 09:54:00-04:00,NSPR,positive
921154.0,8 Biggest Mid-Day Gainers For Tuesday,2016-10-11 12:28:00-04:00,NSPR,neutral
921155.0,InspireMD Announces 1 For 25 Reverse Split,2016-09-28 16:01:00-04:00,NSPR,neutral
921156.0,"InspireMD reports Q2 EPS $(0.16) vs. Est. $(0.17), Rev. $500K vs. Est. $800K",2016-08-09 16:36:00-04:00,NSPR,neutral
921157.0,Mid-Afternoon Market Update: IntriCon Drops On Weak Forecast; Thor Industries Shares Spike Higher,2016-07-01 14:32:00-04:00,NSPR,negative
921158.0,9 Biggest Mid-Day Losers For Friday,2016-07-01 13:15:00-04:00,NSPR,negative
921159.0,InspireMD Announces Pricing of Public Offering of Approximately $14.6M,2016-07-01 04:57:00-04:00,NSPR,neutral
921160.0,InspireMD Names Dr. James Barry CEO,2016-06-07 08:02:00-04:00,NSPR,neutral
921161.0,"InspireMd Reports Q1 EPS $(0.32) vs Est. $(0.35), Rev. $600K vs. Est. $700K",2016-05-10 08:30:00-04:00,NSPR,neutral
921162.0,"Benzinga's M&A Chatter for Wednesday April 20, 2016",2016-04-20 19:55:00-04:00,NSPR,neutral
921163.0,InspireMD Reports Received Audit Opinion with Going-Concern Explanation,2016-03-31 17:57:00-04:00,NSPR,neutral
921164.0,"Rodman & Renshaw Maintains Buy on InspireMD, Lowers PT to $3.00",2016-03-29 07:05:00-04:00,NSPR,negative
921165.0,"InspireMD Reports Q4 EPS $(0.37) vs. Est. $(0.46), Rev. $516K vs. Est. $800K",2016-03-28 08:28:00-04:00,NSPR,neutral
921166.0,InspireMD Prices 1.9M Share Offering At $0.59/Share,2016-03-16 08:30:00-04:00,NSPR,positive
921167.0,InspireMD Reports Proposed Stock & Warrant Offering,2016-03-15 17:01:00-04:00,NSPR,neutral
921168.0,InspireMD Names Isaac Blech Vice Chair,2016-01-22 08:01:00-05:00,NSPR,neutral
921169.0,Benzinga's Top Initiations,2016-01-07 09:37:00-05:00,NSPR,positive
921170.0,"H.C. Wainwright Initiates Coverage on InspireMD at Buy, Announces $4.00 PT",2016-01-07 07:03:00-05:00,NSPR,neutral
921171.0,InspireMD Receives EU Regulatory Approval for Additional Supplier of CGuard Delivery Catheters,2015-12-02 08:00:00-05:00,NSPR,positive
921172.0,InspireMD Reports Positive Twelve Month Follow-Up CARENET Trial Data at VEITH Symposium 2015,2015-11-20 07:35:00-05:00,NSPR,positive
921173.0,"InspireMD Reports Q3 Adj. EPS $(0.36) vs $(0.50) Est., Sales $600K vs $632K Est.",2015-11-10 07:04:00-05:00,NSPR,neutral
921174.0,InspireMD Reports Approval of CGuard in Argentina,2015-10-19 08:03:00-04:00,NSPR,positive
921175.0,InspireMD Reports 1-for-10 Reverse Split,2015-10-01 08:01:00-04:00,NSPR,neutral
921176.0,InspireMD Announces the Issuance of Two United States Patents,2015-09-17 08:02:00-04:00,NSPR,positive
921177.0,InspireMD Announces Allowance of US Patent Claims,2015-09-09 08:10:00-04:00,NSPR,neutral
921178.0,"InspireMD Reports Q2 Adj. Loss of $0.04/Share vs Loss of $0.05/Share Est., Sales $700K vs $900K Est.",2015-08-05 16:11:00-04:00,NSPR,negative
921179.0,"InspireMD Reports Inline Q1 Loss $0.10, Sales $477K, no estimates available",2015-05-11 08:02:00-04:00,NSPR,negative
921180.0,InspireMD Reports Approval of MGuard Prime in Brazil,2015-04-27 08:14:00-04:00,NSPR,positive
921181.0,"InspireMD Reports Closing of Sales Restructuring Program: Q1 Sales $500K vs $850K Est., Sees Cash Projections Remaining On Track",2015-04-15 08:07:00-04:00,NSPR,neutral
921182.0,Oppenheimer Downgrades InspireMD to Perform,2015-03-13 07:17:00-04:00,NSPR,neutral
921183.0,"InspireMD announces Closing Of Offering, Proceeds Total Approx. $13.7M",2015-03-09 16:53:00-04:00,NSPR,neutral
921184.0,InspireMD Prices Offering of 34M Shares at $0.40/Share,2015-03-04 07:53:00-05:00,NSPR,positive
921185.0,InspireMD Announces Proposed Public Offering of Common Stock and Warrants,2015-03-03 16:15:00-05:00,NSPR,neutral
921186.0,InspireMD Receives CE Mark Approval for Its New CGuard RX and Announces Positive Six Month Follow-Up CARENET Trial Data at LINC 2015,2015-01-27 08:32:00-05:00,NSPR,positive
921187.0,InspireMD Announces Notification of NYSE MKT Listing Deficiency,2015-01-21 16:09:00-05:00,NSPR,neutral
921188.0,InspireMD To Announce Positive Six Month Results From CGuardTM CARENET Trial at LINC 2015,2015-01-13 08:34:00-05:00,NSPR,positive
921189.0,InspireMD Sees Q4 Sales $900.0K vs $700.0K Est,2015-01-05 16:33:00-05:00,NSPR,neutral
921190.0,"InspireMD Announces Important Clincial Data from MASTER, CARENET Trials: Pooled Data Showed Statistically Significant Mortality Benefit",2014-12-15 08:37:00-05:00,NSPR,positive
921191.0,"InspireMD Announces Important Clinical Data From MASTER, CARENET Trials",2014-12-15 08:35:00-05:00,NSPR,positive
921192.0,"InspireMD Reports Q3 Loss of $0.20/Share vs Loss of $0.22/Share Est., Sales of $273K vs $1.55M in Same Qtr. Last Year",2014-11-12 16:13:00-05:00,NSPR,negative
921193.0,Morning Market Losers ,2014-11-04 09:58:00-05:00,NSPR,negative
921194.0,InspireMD Announces Registered Direct Offering For Approximately $8M,2014-11-04 09:28:00-05:00,NSPR,neutral
921195.0,InspireMD Investigational Device Exemption Amendment Approved By FDA ,2014-10-29 09:10:00-04:00,NSPR,positive
921196.0,"InspireMD Announces Resumption of MGuard Prime Sales, Prioritizes DES, Carotid, Master II Trial to Suspend Enrollment, Will Not Resume Enrollment in Trial for ST",2014-10-14 07:33:00-04:00,NSPR,negative
921197.0,InspireMD Announces Initial Commercial Sales Of The CGuard EPS,2014-10-01 08:41:00-04:00,NSPR,neutral
921198.0,InspireMD Announces Positive Results from CGuard CARENET Trial with 0% MACE reported at 30 Days ,2014-09-16 16:10:00-04:00,NSPR,positive
921199.0,InspireMD Announces James Barry COO,2014-07-15 08:31:00-04:00,NSPR,neutral
921200.0,InsireMD Announces Completion of Enrollment of CGuard Carenet Enrollment ,2014-07-08 08:36:00-04:00,NSPR,neutral
921201.0,Morning Market Losers ,2014-06-23 09:44:00-04:00,NSPR,negative
921202.0,"InspireMD Announces Has Received European Regulatory Approval to Resume Manufacturing, Distribution of MGuard(TM) Prime EPS",2014-06-23 08:31:00-04:00,NSPR,positive
921203.0, InspireMD Initiated Voluntary Field Action for MGuard Prime EPS -8-K,2014-04-30 12:42:00-04:00,NSPR,neutral
921204.0,UPDATE: Oppenheimer Initiates Coverage on InspireMD on Novel Solution for STEMI,2013-11-26 12:56:00-05:00,NSPR,positive
921205.0,InspireMD Announces New Appointment to the Board of Directors,2013-09-04 09:01:00-04:00,NSPR,neutral
921206.0,InspireMD Wins FDA Approval to Begin US Regulatory Trial for IDE App,2013-04-23 08:44:00-04:00,NSPR,positive
